In her Tuesday newsletter, Lily Belli notes a reshuffling at downtown Santa Cruz's Abbott Square Market, reviews the new ...
Business owners Michael Spadafora and Patrice Boyle reflect on a tumultuous year for their businesses as the Murray Street ...
The Edmonds-Woodway High School Jazz Ensemble I has been to be selected for 2026 Starbucks Hot Java Cool Jazz concert, EWHS ...
BUY MERCH AT PLAY ON THE NEW MINECRAFT SERVER JAVA EDITION IP Address: play.gamersreact.net SUBMIT CLIPS: Discord twitter instagram tik tok @gamersreactyt Background Music: "Night out" by LiQWYD ...
A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The ...
Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ...
Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...
Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...
Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...
Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...
Nov 21 (Reuters) - Eli Lilly (LLY.N), opens new tab hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its ...
Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...